From bench to bedside: current development and emerging trend of KRAS-targeted therapy

Chen, Y; Liu, QP; Xie, H; Ding, J

Xie, H; Ding, J (通讯作者)，Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.;Xie, H; Ding, J (通讯作者)，Univ Chinese Acad Sci, Beijing 100049, Peoples R China.;Xie, H (通讯作者)，Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528400, Peoples R China.

ACTA PHARMACOLOGICA SINICA, 2023; ():

Abstract

Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most frequently mutated oncogene in human cancers with mutations predominantly occurring in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索